General Information of Drug Formulation (ID: F11472)

Formulation Name
Levetiracetam 250 mg tablet
Company
Avera McKennan Hospital; Camber Pharmaceuticals; RemedyRepack
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Levetiracetam DMTGDN8 Epilepsy 8A60-8A68 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Carmellose sodium E00625 Not Available Disintegrant
FD&C blue no. 2 E00446 2723854 Colorant
Magnesium stearate E00208 11177 lubricant
Polyethylene glycol 3350 E00652 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polyvinyl alcohol E00666 Not Available Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Povidone E00667 Not Available Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Silicon dioxide E00670 Not Available Anticaking agent; Opacifying agent; Viscosity-controlling agent
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent